This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bok, L. A.
Right arrow Articles by Duran, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bok, L. A.
Right arrow Articles by Duran, M.
Related Collections
Right arrow Nutrition & Metabolism
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
PEDIATRICS Vol. 112 No. 5 November 2003, pp. 1152-1155

Short-Chain Acyl-CoA Dehydrogenase Deficiency: Studies in a Large Family Adding to the Complexity of the Disorder

Levinus A. Bok, MD*, Peter Vreken, PhD{ddagger},{dagger}, Frits A. Wijburg, MD, PhD{ddagger}, Ronald J. A. Wanders, PhD{ddagger}, Niels Gregersen, PhD§, Morten J. Corydon, PhD§, Hans R. Waterham, PhD{ddagger} and Marinus Duran, PhD{ddagger}

* Maxima Medisch Centrum, Veldhoven, The Netherlands
{ddagger} Academic Medical Center, University of Amsterdam, Department of Clinical Chemistry and Division of Emma’s Children’s Hospital, Amsterdam, The Netherlands
§ Research Institute for Molecular Medicine, Faculty of Health Sciences and Aarhus University Hospital, Aarhus N, Denmark

Objective. To understand the expanding clinical and biochemical spectrum of short-chain acyl-CoA dehydrogenase (SCAD) deficiency, the impact of which is not fully understood.

Study Design. We studied a family with SCAD deficiency and determined urinary ethylmalonic acid excretion, plasma C4-carnitine, SCAD enzyme activity in fibroblasts and lymphocytes, DNA mutations in the SCAD gene, and clinical expression. The index patient was born prematurely and had otherwise unexplained cholestasis and hepatomegaly during the first year of life. His mother developed a hemolysis-elevated liver enzymes-low platelets (HELLP) syndrome while pregnant with the index patient.

Results. Two siblings had a homozygous inactivating 1138C>T mutation, whereas the father was compound heterozygous for this mutation and the common 625G>A polymorphism. There was a good correlation between the type of SCAD mutation, the residual SCAD enzyme activity, and the levels of urinary ethylmalonic acid and plasma C4-carnitine in each of the eight family members. Retrospective acylcarnitine analysis of the index patient’s Guthrie screening card confirmed the abnormal increase of C4-carnitine, suggestive of SCAD deficiency. None of the family members had hypotonia, developmental delay, or episodes of ketotic hypoglycemia.

Conclusion. Homozygosity for an inactivating SCAD mutation does not necessarily result in disease. The previously held opinion that SCAD deficiency is always a serious disorder may have been influenced by a clinical bias. Homozygosity for an inactivating 1138C>T SCAD mutation was assessed by neonatal screening of blood spot acylcarnitines. SCAD deficiency may be associated with maternal HELLP syndrome.

Key Words: mitochondrial fatty acid oxidation • short-chain acyl-CoA dehydrogenase • ethylmalonic acid • butyrylcarnitine • inactivating mutations

Abbreviations: SCAD, short-chain acyl-CoA dehydrogenase • EMA, ethylmalonic acid • HELLP, hemolysis-elevated liver enzymes-low platelets

Received for publication Mar 22, 2002; Accepted Jan 30, 2003.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
B. T. van Maldegem, M. Duran, R. J. A. Wanders, K. E. Niezen-Koning, M. Hogeveen, L. Ijlst, H. R. Waterham, and F. A. Wijburg
Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.
JAMA, August 23, 2006; 296(8): 943 - 952.
[Abstract] [Full Text] [PDF]